Expert: AI-generated pathogens overestimated, designer drugs underestimated
davidmanheim · x · 2026-08-26
David Manheim argues that AI-generated pathogens might be overestimated, while AI-designed drugs, such as potent party drugs with low side effects, are underestimated. He notes that safe drug design is as difficult as viral design, both bottlenecked by predicting immune responses, though drugs have fewer degrees of freedom.
Related event: Researcher Warns AI-Designed Drugs Pose Underestimated Risk(2 posts)→
More from AGI Musings
- AI Transparency Exceeds Expectations: 2025 Prediction Review — MariusHobbhahn · 2026-08-26
- Model capability likely to dominate media in coming weeks amid intelligence jumps — iruletheworldmo · 2026-08-26
- VC Stewart Alsop: LLM outputs never match intent — it's a desire problem, not technical — StewartalsopIII · 2026-08-26
- Peter Diamandis: Today Is the Slowest Rate of Change You Will Experience — PeterDiamandis · 2026-08-26
- Creator laments: AI assumed in art, stealing human authenticity — MannerNo7000 · 2026-08-26
- a16z Partner: Distinction between training and inference will become meaningless — Kyrannio · 2026-08-26